EMERGENCY:Autonomic crisis in a familial dysautonomia patient — severe vomiting, high blood pressure, profuse sweating —call040-46324365immediately — 24 hours, 7 days— 24/7
Familial dysautonomia (FD), also known as Riley-Day syndrome or hereditary sensory and autonomic neuropathy type III (HSAN III), is an autosomal recessive genetic disorder of the autonomic and sensory nervous systems caused by mutations in the IKBKAP gene (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) on chromosome 9q31. IKBKAP encodes a protein (elongator protein 1 or ELP1) that is essential for normal neuronal development and survival. Without functional ELP1, the neurons of the autonomic ganglia, dorsal root ganglia, and peripheral sensory nerves fail to develop and survive normally, producing a progressive loss of autonomic and sensory neurons throughout life.
Familial dysautonomia (FD) is an autosomal recessive disorder of the autonomic and sensory nervous systems caused by the IKBKAP gene (chromosome 9q31) encoding ELP1 (elongator protein 1), essential for autonomic and sensory neuron development and survival. Without functional ELP1, autonomic ganglia neurons, dorsal root ganglia neurons, and peripheral sensory fibres fail to develop and survive, producing progressive autonomic and sensory loss. Almost exclusively an Ashkenazi Jewish disease: carrier frequency 1 in 30; prevalence 1 in 3,600 Ashkenazi births; >99% share the same founder splice-site mutation (IVS20+6T>C). Five diagnostic criteria: (1) absent fungiform papillae (smooth tongue, no taste buds — a classic and highly characteristic feature, strongly suggestive but not pathognomonic alone; molecular ELP1 confirmation required); (2) absent histamine flare; (3) absent deep tendon reflexes; (4) methacholine miosis (denervation supersensitivity); (5) Ashkenazi ancestry. Autonomic crises: episodic hypertension + profuse vomiting + diaphoresis + skin blotching + tachycardia, triggered by emotional stress or physical illness. Corneal anaesthesia: no blink reflex to corneal touch → corneal ulceration risk → mandatory lubricating drops every 1–2 hours. Anaesthesia: avoid volatile agents; use TIVA; peri-operative clonidine + benzodiazepines for crisis prevention. Survival >50% beyond age 30 with comprehensive multidisciplinary care.
| Fact | Details |
|---|---|
| Pathognomonic | Absent fungiform papillae · Smooth tongue · Simple torch examination · No other condition causes this consistently |
| Genetics | IKBKAP (ELP1) gene, chromosome 9q31 · Autosomal recessive · Ashkenazi: carrier 1:30, prevalence 1:3,600 · >99% share IVS20+6T>C founder mutation |
| 5 diagnostic criteria | (1) Absent fungiform papillae · (2) Absent histamine flare · (3) Absent deep tendon reflexes · (4) Methacholine miosis · (5) Ashkenazi ancestry |
| Autonomic crises | Hypertension + vomiting + diaphoresis + skin blotching · Diazepam + clonidine + IV fluids · Prevention: regular clonidine |
| Corneal care | No blink reflex = ulceration risk · Preservative-free drops every 1–2h awake · Ointment at night · Moisture chamber glasses · Ophthalmology review mandatory |
| Anaesthesia | TIVA only (no volatile agents) · Pre-op clonidine + benzodiazepines · Extended HDU monitoring post-operatively · Communicate FD diagnosis to anaesthetic team before every procedure |
| Prognosis | >50% survival beyond age 30 with comprehensive multidisciplinary care · Gastrostomy reduces aspiration · Scoliosis management preserves lung function |
1 in 3,600 Ashkenazi Jewish births · Carrier frequency: 1 in 30 Ashkenazi Jews · Extremely rare in non-Ashkenazi populations.
IKBKAP (ELP1) on chromosome 9q31 · Autosomal recessive · >99% of mutations: the same splice-site mutation (IVS20+6T>C) in Ashkenazi patients.
Absent fungiform papillae (the tongue has no small raised bumps = smooth tongue) · Absent flare response to intradermal histamine · No overflow tearing (alacrima) · Absent deep tendon reflexes.
Autonomic crises: episodic hypertension + nausea + vomiting + diaphoresis + skin blotching + tachycardia · Orthostatic hypotension · Poor temperature regulation · Periodic breathing during sleep.
Reduced pain and temperature sensation · Corneal anaesthesia (no blink response to corneal touch — risk of corneal ulceration) · No tongue taste function (absent fungiform papillae = absent taste buds).
Dysphagia (oropharyngeal and oesophageal dysmotility) · Chronic aspiration · Vomiting crises.
Chronic aspiration lung disease · Abnormal ventilatory response to hypoxia and hypercapnia · Breath-holding spells in infancy.
No curative treatment · Tocotrienol (vitamin E analogue) and kinetin: partially correct splicing defect in vitro, trials ongoing · Autonomic crisis: diazepam, clonidine · Eye lubrication for corneal protection · Gastrostomy for feeding.
Almost exclusively Ashkenazi Jewish · Small Jewish communities in Mumbai/Kolkata/Pune · Genetic counselling for carrier couples · Prenatal diagnosis available.
Familial dysautonomia (FD), also known as Riley-Day syndrome or hereditary sensory and autonomic neuropathy type III (HSAN III), is an autosomal recessive genetic disorder of the autonomic and sensory nervous systems caused by mutations in the IKBKAP gene (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) on chromosome 9q31. IKBKAP encodes a protein (elongator protein 1 or ELP1) that is essential for normal neuronal development and survival. Without functional ELP1, the neurons of the autonomic ganglia, dorsal root ganglia, and peripheral sensory nerves fail to develop and survive normally, producing a progressive loss of autonomic and sensory neurons throughout life.
Familial dysautonomia is almost exclusively an Ashkenazi Jewish disease — the carrier frequency in the Ashkenazi Jewish population is approximately 1 in 30, making it the most common serious genetic disease in this population (prevalence approximately 1 in 3,600 Ashkenazi Jewish births). In India, FD is extremely rare and would be encountered primarily in the small Ashkenazi Jewish communities (Bene Israel, Baghdadi Jews) in Mumbai and Kolkata, and in the medical context of a visiting family or a patient who has relocated from Israel or the USA. Understanding FD is important for KIMS as a tertiary referral centre that receives patients from across the country and internationally.
Speak directly with the KIMS familial dysautonomia team — clinical genetics, autonomic neurology, pulmonology, ophthalmology, gastroenterology, orthopaedics, anaesthesia, and nutrition coordinated for the lifelong supportive care pathway.
040-44885000Multidisciplinary FD evaluationFungiform papillae are the small, rounded protuberances on the anterior two-thirds of the tongue that contain the taste receptor cells. In familial dysautonomia, these papillae are absent from birth — the tongue appears smooth and featureless rather than having the normal textured appearance. Absent fungiform papillae is a highly characteristic and strongly suggestive clinical feature of FD, but it is not pathognomonic in isolation — absent papillae alone is not sufficient to establish the diagnosis. Diagnosis requires the complete clinical picture (all five criteria together) plus molecular confirmation of biallelic pathogenic variants in the ELP1/IKBKAP gene. Examining the tongue with a torch is a simple bedside test. No fungiform papillae + autonomic instability + Ashkenazi Jewish ancestry = familial dysautonomia until proven otherwise.
Autonomic crises (also called dysautonomic crises) are episodes of severe autonomic dysregulation lasting hours to days, characterised by: hypertensive surges (BP >160/100) · Nausea and vomiting (often protracted) · Profuse diaphoresis · Skin blotching (areas of erythema from vasodilation) · Tachycardia · Personality change and irritability. They are the most distressing and dangerous feature of FD, triggered by emotional stress, physical illness, or surgery. Management of acute crises: diazepam (reduces sympathetic outflow) + clonidine (central alpha-2 agonist reducing sympathetic output) + IV fluids + antiemetics + a quiet, calm environment. Hospitalisation is often required for severe crises.
Because FD patients have reduced or absent corneal sensation (no blink reflex to corneal touch), they do not feel when the cornea is dry, irritated, or abraded. This leads to corneal ulceration — which, if undetected and untreated, can progress to corneal perforation and permanent vision loss. Eye care in FD is mandatory and lifelong: preservative-free artificial tears during the day (every 1–2 hours while awake) · Lubricating eye ointment at night · Moisture chamber glasses during sleep · Regular ophthalmology review · Prompt ophthalmology assessment for any redness, discharge, or visual change.
Scoliosis develops in the majority of patients with FD due to muscle weakness and hypotonia combined with sensory loss (which normally contributes to postural proprioceptive feedback). It is often severe and rapidly progressive. Annual spine X-ray monitoring from early childhood. Bracing for moderate curves. Spinal fusion surgery for severe or progressive curves affecting pulmonary function.
Familial dysautonomia is diagnosed and assessed at KIMS through a structured four-stage workflow that begins with the five clinical criteria (absent fungiform papillae, absent histamine flare, absent deep tendon reflexes, methacholine miosis, Ashkenazi ancestry) confirmed by IKBKAP genetic testing, expands to autonomic function testing with 24-hour BP monitoring, thermoregulation, and Schirmer testing, evaluates pulmonary function and aspiration risk with HRCT, swallow assessment, and polysomnography, and characterises the nutritional status with gastrostomy planning :
Criteria for FD diagnosis (all must be present): (1) Absent fungiform papillae · (2) Absent flare response to intradermal histamine (0.1 mg/0.1 mL in volar forearm — no surrounding erythematous flare) · (3) Absent deep tendon reflexes · (4) Miosis with methacholine (pupillary constriction with dilute methacholine due to denervation supersensitivity) · (5) Ashkenazi Jewish ancestry. IKBKAP genetic testing confirms the diagnosis.
Cardiovascular autonomic testing (as per dysautonomia page) · 24-hour BP monitoring (supine hypertension + orthostatic hypotension pattern) · Temperature regulation testing (thermoregulatory sweat test: impaired or absent) · Ophthalmology (Schirmer test for alacrima: reduced tear production).
Pulmonary function tests · HRCT chest (for aspiration lung disease: lower lobe bronchiectasis) · Modified barium swallow / videofluoroscopy for aspiration risk assessment · Polysomnography (for periodic breathing and sleep-disordered breathing from abnormal ventilatory drive).
Oropharyngeal dysphagia + chronic aspiration + vomiting crises = severe nutritional risk. Gastrostomy (PEG or G-tube) is recommended when: recurrent aspiration pneumonia · Weight loss despite oral intake · Vomiting crises causing dehydration and electrolyte disturbance. Nutritional support via gastrostomy dramatically reduces aspiration pneumonia frequency and improves growth.
Related Conditions
Familial dysautonomia belongs to the family of autonomic nervous system disorders evaluated and managed at KIMS Neuroscience. Explore related conditions.
A smooth tongue with no bumps. No tears when crying. A blood pressure that swings dangerously during stress. Familial dysautonomia is rare but it has a specific diagnosis, a specific community, and a structured multidisciplinary care plan.
At KIMS Hyderabad, the clinical genetics and autonomic neurology teams provide the full FD evaluation and ongoing management. Call 040-44885000.
International enquiries: info@kimsneurosciences.com